These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Translating in vitro ligand bias into in vivo efficacy. Luttrell LM; Maudsley S; Gesty-Palmer D Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495 [TBL] [Abstract][Full Text] [Related]
23. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors. Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258 [TBL] [Abstract][Full Text] [Related]
24. Molecular Mechanisms of GPCR Signaling: A Structural Perspective. Gurevich VV; Gurevich EV Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186792 [TBL] [Abstract][Full Text] [Related]
25. GPCR structure and function relationship: identification of a biased apelin receptor mutant. Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826 [TBL] [Abstract][Full Text] [Related]
27. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways. Liu Y; Yang Y; Ward R; An S; Guo XX; Li W; Xu TR Biochem J; 2015 Sep; 470(2):155-67. PubMed ID: 26348905 [TBL] [Abstract][Full Text] [Related]
28. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899 [TBL] [Abstract][Full Text] [Related]
29. Many faces of the GPCR-arrestin interaction. Kim K; Chung KY Arch Pharm Res; 2020 Sep; 43(9):890-899. PubMed ID: 32803684 [TBL] [Abstract][Full Text] [Related]
36. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists. Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM Front Pharmacol; 2015; 6():131. PubMed ID: 26191004 [TBL] [Abstract][Full Text] [Related]
37. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371 [TBL] [Abstract][Full Text] [Related]
38. Chemical biology methods for investigating G protein-coupled receptor signaling. Huber T; Sakmar TP Chem Biol; 2014 Sep; 21(9):1224-37. PubMed ID: 25237865 [TBL] [Abstract][Full Text] [Related]
39. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574 [TBL] [Abstract][Full Text] [Related]
40. GPCR systems pharmacology: a different perspective on the development of biased therapeutics. Eiger DS; Pham U; Gardner J; Hicks C; Rajagopal S Am J Physiol Cell Physiol; 2022 May; 322(5):C887-C895. PubMed ID: 35196164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]